Main Article Content
In whole, 56 patients were included. Amidst identified microorganisms were fungus (4,7%) and bacteria (95,3%) to which Gram negative bacilli represented 72,1% (n=44), Gram positive cocci 6,4% (n=10), Gram positive bacilli 8,2% (n=5) and Gram negative cocci 3,3% (n=2). Among these bacterias, Pseudomonas aeruginosa and Proteus sp were predominant, with respectively 41% (n=25), 23% (n=14). However, three cases of S. aureus reported, six with negative coagulase Staphylococcus, one with Escherichia coli, one with Klebsiella sp, one with Haemophilus sp, two cases with Neisseria sp and four cases with Corynebacterium sp. Two types of cultures were noticed, one of them monomorphic (91,1%, n=51) and the other polymorphic (8,9%, n=5) to which 3 associations of P. aeruginosa-Proteus sp, 1 association of P. aeruginosa- coagulase negative Staphylococcus and 1 association of P. aeruginosa- E. coli. No resistance to ciprofloxacin was observed with Pseudomonas, Neisseria sp, Haemophilus, and enterobacteria except for E. coli. No resistance to rifampicin was observed with S. aureus. However, the sensitivity of S. aureus to ciprofloxacin decreased (one bacterium out of three).
The use of rifampicin or fluoroquinolones should be based on the type of ear infections,
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
Gehanno P. Epidémiologie bactérienne et analyse critique des essais thérapeutiques dans l’otite. Méd Mal Infect. 1992; 22: 114–129.
Martines F, Bentivegna D, Sciacca V, Enrico M. Risk factors for otitis media with effusion: Case–control study in Sicilian schoolchildren. Int J Pediatr Otorhinolaryngol 2011; 75(6): 754‑759.
Bayeh A, Mulugeta K. Bacteriology and antimicrobial susceptibility of otitis media at dessie regional health research laboratory, Ethiopia. Ethiop J Health Dev.2011; 25(2): 161–167.
Raghu Kumar KG. A Study of Bacterial Profile and Antibiotic Susceptibility Pattern of Chronic Suppurative Otitis Media among Patients attending a Tertiary Care Centre, Davangere. Sch J App Med Sci. 2014; 2(5B): 1606‑1612.
Oyeleke Solomon. Screening for bacteria agents responsible for otitis media and their antibiogram. Afr J Microbiol Res. 2009; 3(5): 249–252.
Meyer E, Whitelaw A, Edkins O, Fagan J. Chronic otorrhoea: Spectrum of microorganisms and antibiotic sensitivity in a South African cohort. S Afr Med J. 2013; 103(7): 471-473.
Kiakojuri K, Mahdavi Omran S, Bahareh J, Hajiahmadi M and al. Bacterial Otitis Externa in Patients Attending an ENT Clinic in Babol, North of Iran. Jundishapur J Microb. 2016; 9(2): 1‑5.
Roland P, Stroman D. Microbiology of acute otitis externa. Laryngoscope. 2002; 112(7): 1166–1177.
Husson M O, Vincent C. Étude de l’épidémiologie bactérienne de l’otite moyenne aiguë de l’enfant observée en ville dans la région Nord Pas-de-Calais. Pathol Biol. 2001; 49: 789‑793.
Vergison A, Dagan R, Arguedas A. Otitis media and its consequences: Beyond the earache. Lancet Infect Dis. 2010; 10(3): 195-203.
Tanmoy D, Debabrata R. A Study of the Bacteriological Profile of Chronic Suppurative Otitis Media in Agartala. Indian J Otolaryngol Head Neck Surg. 2012; 64(4): 326‑329.
Sacko H, Diallo A O. Bactériologie de l’otite moyenne suppurée chronique de l’enfant au Mali. J Tun ORL. 2014; 31(1): 34–36.
Pessey JJ, Ovetchkine P, Dumarcet N. Antibiothérapie locale en ORL Recommandation de bonne pratique. Médecine thérapeutique. 2004; 10(5) : 356-359.
Muhammad I. Chronic suppurative otitis media : frequency and sensivity pattern of Pseudomonas aeruginosa. Journal of Medical Science 2012; 20(4):181‑183.
Egbe C, Mordi R, Omoregie R, Enabulele O. Prevalence of Otitis Media in Okada Community, Edo State, Nigeria. Mac J Med Sci. 2010; 3(3): 299‑302.
Kailash W, Shubhangi g. Bacterial and fungal study in chronic suppurative otitis media from a developing country. Int J Mod Trends Sci Technol. 2015; 16(1): 104‑108.